Renaissance Technologies’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.06M | Sell |
489,600
-33,500
| -6% | -$483K | 0.01% | 1299 |
|
|
2025
Q1 | $3.61M | Sell |
523,100
-189,688
| -27% | -$1.31M | 0.01% | 1627 |
|
|
2024
Q4 | $3.78M | Buy |
712,788
+288,588
| +68% | +$1.53M | 0.01% | 1621 |
|
|
2024
Q3 | $1.55M | Buy |
424,200
+8,100
| +2% | +$29.6K | ﹤0.01% | 2181 |
|
|
2024
Q2 | $1.14M | Buy |
416,100
+32,400
| +8% | +$88.5K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $1.34M | Sell |
383,700
-85,602
| -18% | -$298K | ﹤0.01% | 2301 |
|
|
2023
Q4 | $671K | Buy |
469,302
+24,390
| +5% | +$34.9K | ﹤0.01% | 2632 |
|
|
2023
Q3 | $650K | Sell |
444,912
-15,627
| -3% | -$22.8K | ﹤0.01% | 2589 |
|
|
2023
Q2 | $723K | Buy |
460,539
+33,339
| +8% | +$52.3K | ﹤0.01% | 2680 |
|
|
2023
Q1 | $654K | Sell |
427,200
-143,700
| -25% | -$220K | ﹤0.01% | 2726 |
|
|
2022
Q4 | $959K | Sell |
570,900
-47,310
| -8% | -$79.5K | ﹤0.01% | 2559 |
|
|
2022
Q3 | $760K | Sell |
618,210
-121,690
| -16% | -$150K | ﹤0.01% | 2661 |
|
|
2022
Q2 | $1.24M | Buy |
739,900
+319,399
| +76% | +$534K | ﹤0.01% | 2567 |
|
|
2022
Q1 | $1.03M | Buy |
420,501
+382,413
| +1,004% | +$940K | ﹤0.01% | 2704 |
|
|
2021
Q4 | $142K | Buy |
+38,088
| New | +$142K | ﹤0.01% | 3616 |
|
|
2021
Q1 | – | Sell |
-235,200
| Closed | -$1.13M | – | 3791 |
|
|
2020
Q4 | $1.13M | Buy |
235,200
+153,819
| +189% | +$738K | ﹤0.01% | 2437 |
|
|
2020
Q3 | $326K | Sell |
81,381
-128,819
| -61% | -$516K | ﹤0.01% | 2967 |
|
|
2020
Q2 | $965K | Buy |
+210,200
| New | +$965K | ﹤0.01% | 2556 |
|
|
2019
Q4 | – | Sell |
-39,900
| Closed | -$157K | – | 3793 |
|
|
2019
Q3 | $157K | Buy |
+39,900
| New | +$157K | ﹤0.01% | 3201 |
|
|
2018
Q1 | – | Sell |
-45,100
| Closed | -$265K | – | 3624 |
|
|
2017
Q4 | $265K | Buy |
+45,100
| New | +$265K | ﹤0.01% | 3059 |
|